2', 3'-cyclic nucleotide 3'-phosphohydrolase activity in postmortem human spinal fluids.

K Fan

doi:10.1016/0304-3940(80)90200-1

Home/Archive/PubMed

PubMed · 6302599

2', 3'-cyclic nucleotide 3'-phosphohydrolase activity in postmortem human spinal fluids.

K Fan

View original source ↗Export metadata ↓

Abstract

The activity of the myelination-related enzyme, 2', 3'-cyclic nucleotide 3'-phosphohydrolase (CNP), was determined in neurologically normal living and postmortem human spinal fluids, for the purpose of examining the differences in enzymatic activity level and stability. A significant elevation of the enzymatic activity was found in the postmortem samples, and the activity in spinal fluid was labile with respect to postmortem time and sample storage conditions. Findings suggest that caution should be exercised in the interpretation of CNP activity in spinal fluid samples.

Explore related subjects

2',3'-Cyclic Nucleotide 3'-Phosphodiesterase 2',3'-Cyclic-Nucleotide Phosphodiesterases Humans Multiple Sclerosis Phosphoric Diester Hydrolases Postmortem Changes Reference Values Temperature Time Factors Journal Article Research Support, U.S. Gov't, Non-P.H.S.

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

K Fan. 1980. 2', 3'-cyclic nucleotide 3'-phosphohydrolase activity in postmortem human spinal fluids.. https://doi.org/10.1016/0304-3940(80)90200-1

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2006

Structural properties of proteins specific to the myelin sheath.

The myelin sheath is an insulating membrane layer surrounding myelinated axons in vertebrates, which is formed when the plasma membrane of an oligodendrocyte or a Schwann cell wraps itself around the axon. A large fraction of the total protein in this membrane layer is comprised of only a small number of individual proteins, which have certain intriguing structural properties. The myelin proteins are implicated in a number of neurological diseases, including, for example, autoimmune diseases and peripheral neuropathies. In this review, the structural properties of a number of myelin-specific proteins are described.

2',3'-Cyclic Nucleotide 3'-Phosphodiesterase↗

PubMed2006

Expression of 2',3'-cyclic nucleotide 3'-phosphodiesterase in the amoeboid microglial cells in the developing rat brain.

Expression of 2',3'-cyclic nucleotide 3'-phosphodiesterase (CNPase) in amoeboid microglial cells (AMC) in developing rat brain from prenatal day 18 (E18) to postnatal day 10 (P10) was demonstrated by immunohistochemistry/immunofluorescence and immunoelectron microscopy both in vivo and in vitro, respectively. Furthermore, real time-polymerase chain reaction (PCR) was performed to determine the expression of CNPase at mRNA level in cultured microglial cells in control conditions and following lipopolysaccharide stimulation. CNPase immunoreactive amoeboid microglia occurred in large numbers in the corpus callosum, subventricular zone and cavum septum pellucidum at P0 but were progressively reduced with age and were undetectable at P14. By immunoelectron microscopy, immunoreaction product was associated primarily with the plasma membrane, filopodial projections and mitochondria in AMC. Real time-PCR analysis revealed that CNPase mRNA was expressed by cultured amoeboid microglia and was significantly up-regulated in microglial activation induced in vitro by lipopolysaccharide. The functional role of CNPase in AMC remains speculative. Given its expression in AMC transiently occurring in the perinatal brain and that it is markedly elevated in activated microglia, it is suggested that the enzyme may be linked to the major functions of the cell type such as release of chemokines and cytokines. In relation to this, CNPase may play a key role associated with transportation of cytoplasmic materials.

2',3'-Cyclic Nucleotide 3'-Phosphodiesterase↗

PubMed2006

Evolution of a neuroprotective function of central nervous system myelin.

The central nervous system (CNS) of terrestrial vertebrates underwent a prominent molecular change when a tetraspan membrane protein, myelin proteolipid protein (PLP), replaced the type I integral membrane protein, P0, as the major protein of myelin. To investigate possible reasons for this molecular switch, we genetically engineered mice to express P0 instead of PLP in CNS myelin. In the absence of PLP, the ancestral P0 provided a periodicity to mouse compact CNS myelin that was identical to mouse PNS myelin, where P0 is the major structural protein today. The PLP-P0 shift resulted in reduced myelin internode length, degeneration of myelinated axons, severe neurological disability, and a 50% reduction in lifespan. Mice with equal amounts of P0 and PLP in CNS myelin had a normal lifespan and no axonal degeneration. These data support the hypothesis that the P0-PLP shift during vertebrate evolution provided a vital neuroprotective function to myelin-forming CNS glia.

2',3'-Cyclic Nucleotide 3'-Phosphodiesterase↗